10.46
price down icon3.42%   -0.37
after-market Handel nachbörslich: 10.61 0.15 +1.43%
loading
Schlusskurs vom Vortag:
$10.83
Offen:
$10.66
24-Stunden-Volumen:
678.34K
Relative Volume:
3.76
Marktkapitalisierung:
$358.31M
Einnahmen:
$7,000
Nettoeinkommen (Verlust:
$-34.48M
KGV:
-10.40
EPS:
-1.0054
Netto-Cashflow:
$-22.13M
1W Leistung:
-5.94%
1M Leistung:
-16.92%
6M Leistung:
-24.80%
1J Leistung:
-15.78%
1-Tages-Spanne:
Value
$10.26
$10.76
1-Wochen-Bereich:
Value
$10.26
$11.25
52-Wochen-Spanne:
Value
$9.85
$17.15

Benitec Biopharma Inc Stock (BNTC) Company Profile

Name
Firmenname
Benitec Biopharma Inc
Name
Telefon
(510) 780-0819
Name
Adresse
3940 TRUST WAY, HAYWARD, CA
Name
Mitarbeiter
19
Name
Twitter
@BenitecLtd
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
BNTC's Discussions on Twitter

Compare BNTC vs VRTX, REGN, ARGX, ALNY, ONC

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
BNTC
Benitec Biopharma Inc
10.46 370.98M 7,000 -34.48M -22.13M -1.0054
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.27 123.47B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
766.66 83.60B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
748.72 46.83B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
318.65 43.11B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
297.04 34.79B 4.98B 69.60M 525.67M 0.5198

Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-07 Eingeleitet TD Cowen Buy
2024-12-16 Eingeleitet H.C. Wainwright Buy
2024-12-13 Eingeleitet Robert W. Baird Outperform
2024-10-16 Eingeleitet Oppenheimer Outperform
2024-09-12 Eingeleitet Guggenheim Buy
2024-07-22 Eingeleitet Leerink Partners Outperform
2024-06-13 Eingeleitet Piper Sandler Overweight
2020-10-05 Herabstufung Ladenburg Thalmann Buy → Neutral
2020-04-20 Eingeleitet Ladenburg Thalmann Buy
2016-02-26 Herabstufung Maxim Group Buy → Hold
2015-12-31 Bestätigt Maxim Group Buy
2015-09-16 Bestätigt Maxim Group Buy
Alle ansehen

Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten

pulisher
Mar 01, 2026

(BNTC) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Mar 01, 2026
pulisher
Feb 28, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Feb 28, 2026
pulisher
Feb 26, 2026

Benitec BioPharma stock rating maintained on gene therapy data - Investing.com Nigeria

Feb 26, 2026
pulisher
Feb 23, 2026

Benitec Biopharma Announces Acceptance of Late- Breaking - GlobeNewswire

Feb 23, 2026
pulisher
Feb 23, 2026

Durable BB-301 responses in muscular dystrophy to be detailed at MDA 2026 - Stock Titan

Feb 23, 2026
pulisher
Feb 19, 2026

Benitec Biopharma (BNTC) Stock Analysis: Unpacking A 125% Potential Upside - DirectorsTalk Interviews

Feb 19, 2026
pulisher
Feb 17, 2026

Liquidity Mapping Around (BNTC) Price Events - Stock Traders Daily

Feb 17, 2026
pulisher
Feb 15, 2026

What insider trading reveals about Benitec Biopharma Inc. stockJuly 2025 Opening Moves & Verified Swing Trading Watchlists - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Growth Value: What insider trading reveals about Benitec Biopharma Inc. stockMarket Trend Summary & Smart Money Movement Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Here's Why We're Not At All Concerned With Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Situation - Yahoo Finance

Feb 14, 2026
pulisher
Feb 14, 2026

Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to long-term losses - simplywall.st

Feb 14, 2026
pulisher
Feb 14, 2026

Wall Street Zen Downgrades Benitec Biopharma (NASDAQ:BNTC) to Sell - MarketBeat

Feb 14, 2026
pulisher
Feb 13, 2026

BNTC PE Ratio & Valuation, Is BNTC Overvalued - Intellectia AI

Feb 13, 2026
pulisher
Feb 13, 2026

Benitec Biopharma (NASDAQ:BNTC) Announces Quarterly Earnings Results - MarketBeat

Feb 13, 2026
pulisher
Feb 12, 2026

Benitec Biopharma Inc. (BNTC) Investor Outlook: Analyst Ratings Signal a Promising 104.58% Upside Potential - DirectorsTalk Interviews

Feb 12, 2026
pulisher
Feb 12, 2026

Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update - The Manila Times

Feb 12, 2026
pulisher
Feb 12, 2026

Benitec Biopharma Q2 net loss widens - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

BENITEC BIOPHARMA ($BNTC) Releases Q2 2026 Earnings - Quiver Quantitative

Feb 12, 2026
pulisher
Feb 12, 2026

Benitec Biopharma Inc. SEC 10-Q Report - TradingView

Feb 12, 2026
pulisher
Feb 11, 2026

Is Benitec Biopharma Inc. exposed to political riskSwing Trade & Community Trade Idea Sharing Platform - mfd.ru

Feb 11, 2026
pulisher
Feb 07, 2026

Guidance Update: Is Benitec Biopharma Inc forming a breakout patternTreasury Yields & Technical Pattern Recognition Alerts - baoquankhu1.vn

Feb 07, 2026
pulisher
Feb 06, 2026

Why (BNTC) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Feb 06, 2026
pulisher
Feb 06, 2026

Benitec Biopharma (BNTC) Projected to Post Earnings on Friday - MarketBeat

Feb 06, 2026
pulisher
Feb 04, 2026

Franklin Resources Inc. Expands Stake in Benitec Biopharma Inc. - GuruFocus

Feb 04, 2026
pulisher
Feb 04, 2026

How liquid is Benitec Biopharma Inc stockWeekly Trade Analysis & High Accuracy Swing Trade Signals - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 03, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 03, 2026
pulisher
Feb 02, 2026

Income Plays: Is Benitec Biopharma Inc stock a good dividend stock2025 Key Lessons & Expert-Curated Trade Recommendations - baoquankhu1.vn

Feb 02, 2026
pulisher
Jan 31, 2026

Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade - Seeking Alpha

Jan 31, 2026
pulisher
Jan 31, 2026

Meme Stocks: Is NATH stock a good pick for beginnersInflation Watch & Weekly High Return Forecasts - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 30, 2026

BNTC Stockholders Sell Shares Without Benefit to Company - GuruFocus

Jan 30, 2026
pulisher
Jan 29, 2026

Benitec Biopharma Inc. (BNTC) Investor Outlook: Analysts Predict Nearly 100% Upside Potential - DirectorsTalk Interviews

Jan 29, 2026
pulisher
Jan 29, 2026

Benitec Biopharma (NASDAQ:BNTC) Stock Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat

Jan 29, 2026
pulisher
Jan 28, 2026

Can Benitec Biopharma Inc. maintain its current growth rateJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - mfd.ru

Jan 28, 2026
pulisher
Jan 27, 2026

Understanding Momentum Shifts in (BNTC) - Stock Traders Daily

Jan 27, 2026
pulisher
Jan 26, 2026

Analyst Downgrade: Should I average down on GBTG stockJuly 2025 Earnings & Safe Capital Allocation Plans - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 24, 2026

Hedge Fund Bets: Is Benitec Biopharma Inc forming a double bottomJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 18, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Sees Large Increase in Short Interest - MarketBeat

Jan 18, 2026
pulisher
Jan 16, 2026

Avoiding Lag: Real-Time Signals in (BNTC) Movement - Stock Traders Daily

Jan 16, 2026
pulisher
Jan 13, 2026

Aug Setups: Will Benitec Biopharma Inc face regulatory challengesTrade Entry Report & Accurate Intraday Trading Signals - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

Aug Gainers: How supply chain issues affect Benitec Biopharma Inc stockEarnings Summary Report & Free High Accuracy Swing Entry Alerts - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

Citizens reiterates Market Outperform rating on Benitec BioPharma stock By Investing.com - Investing.com Canada

Jan 13, 2026
pulisher
Jan 12, 2026

Market Wrap: What is the PEG ratio of Benitec Biopharma Inc2025 Growth vs Value & AI Powered Market Entry Ideas - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 12, 2026

Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target - Investing.com Canada

Jan 12, 2026
pulisher
Jan 12, 2026

Baird reiterates Outperform rating on Benitec BioPharma stock at $30 target By Investing.com - Investing.com South Africa

Jan 12, 2026
pulisher
Jan 11, 2026

Benitec Biopharma (BNTC) Reports Promising Results from BB-301 S - GuruFocus

Jan 11, 2026
pulisher
Jan 11, 2026

Benitec Biopharma Inc. Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - marketscreener.com

Jan 11, 2026
pulisher
Jan 11, 2026

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response - Sahm

Jan 11, 2026
pulisher
Jan 10, 2026

Can Benitec Biopharma Inc. stock double in next 5 years2025 Fundamental Recap & AI Forecasted Entry and Exit Points - ulpravda.ru

Jan 10, 2026
pulisher
Jan 09, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Jan 09, 2026
pulisher
Jan 09, 2026

Benitec Biopharma Limited (NASDAQ:BNTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 09, 2026
pulisher
Jan 08, 2026

Is Benitec Biopharma Inc. stock a buy before product launches2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда

Jan 08, 2026

Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$49.83
price down icon 5.71%
$27.85
price down icon 0.89%
$47.48
price up icon 0.02%
$100.76
price down icon 6.25%
$147.00
price up icon 0.46%
biotechnology ONC
$297.04
price down icon 5.51%
Kapitalisierung:     |  Volumen (24h):